| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Gain on sale of an asset | NaN | NaN | NaN | 0 |
| Net income (loss) | 6,526,382 | -804,121 | 752,365 | -963,996 |
| Depreciation | 333,211 | 383,956 | 364,699 | 725,762 |
| Amortization of debt discount | 232,832 | 4,184 | 4,184 | 8,368 |
| Gain on sale of assets | 8,896,309 | NaN | NaN | NaN |
| Provision for credit losses | 20,357 | 540,319 | 106,763 | 235,956 |
| Loss on extinguishment of debt | NaN | 252,970 | NaN | NaN |
| Gain on debt forgiveness | NaN | 173,500 | NaN | NaN |
| Accounts receivable | 232,931 | -376,787 | 258,727 | 661,404 |
| Prepaid expenses and other assets | 263,901 | -71,604 | -56,990 | 168,397 |
| Accounts payable and accrued liabilities | 1,291,102 | -334,729 | -748,246 | 1,375,843 |
| Liabilities held for sale | 577,055 | NaN | NaN | NaN |
| Other current liabilities | -725,000 | 325,000 | 0 | 400,000 |
| Lease security deposits | 1,500 | 1,500 | 2,000 | 5,900 |
| Cash (used in) provided by operating activities | -2,289,812 | 643,970 | 280,028 | 958,032 |
| Proceeds from sale of assets held for sale, net | 5,401,131 | NaN | NaN | 0 |
| Cash paid for property and equipment | 377,201 | 56,623 | 4,233 | 382,755 |
| Cash provided by (used in) investing activities | 5,023,930 | -56,623 | -4,233 | -382,755 |
| Proceeds from debt, non-related party | NaN | NaN | 0 | 50,000 |
| Proceeds on debt, non-related party | NaN | 50,000 | NaN | NaN |
| Payments on debt, related party | 775,000 | NaN | NaN | NaN |
| Payments on debt, non-related party | 1,959,038 | 2,109,309 | -357,084 | -593,863 |
| Proceeds from line of credit | NaN | 250,749 | 200,000 | 13,258 |
| Payments on line of credit | NaN | 331,337 | NaN | NaN |
| Repurchase of preferred stock | 50,000 | NaN | NaN | NaN |
| Dividends paid on preferred stock | NaN | 1,000 | NaN | NaN |
| Payments on line-of-credit | -6,146 | NaN | 226,623 | 104,715 |
| Cash used in financing activities | -3,109,230 | 42,335 | -383,707 | -635,320 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -375,112 | 629,682 | -107,912 | -60,043 |
| Cash and cash equivalents and restricted cash at beginning of the period | 1,853,693 | 1,224,011 | 1,391,966 | NaN |
| Cash and cash equivalents and restricted cash at end of the period | 1,478,581 | 1,853,693 | 1,224,011 | NaN |
SELECTIS HEALTH, INC. (GBCS)
SELECTIS HEALTH, INC. (GBCS)